NGM Biopharmaceuticals
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has NGM Biopharmaceuticals's balance sheet done over the years? Its assets were worth $168,868,000 last year, which is less than in the previous period. 12% of NGM Biopharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $20,230,000, which means an decrease by -58% compared compared to last year.
Debt to Assets
| 2016 | 276994000 | 392.05M | 141.54% |
|---|---|---|---|
| 2017 | 248941000 | 369.91M | 148.6% |
| 2018 | 246085000 | 59.20M | 24.06% |
| 2019 | 380403000 | 49.68M | 13.06% |
| 2020 | 329043000 | 49M | 14.89% |
| 2021 | 402387000 | 66.74M | 16.59% |
| 2022 | 307402000 | 47.84M | 15.56% |
| 2023 | 168868000 | 20.23M | 11.98% |
NGM Balance Sheet (2016 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
Assets | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | 58.81M | 73.45M | 151.79M | 147.01M | 245.59M | 56.92M | 25.59M | 45.46M |
Short term investments | 88.36M | 198.03M | 214.45M | 148.13M | 98.91M | 149.71M | 148.09M | 184.72M |
Net receivables | 58K | 7.58M | 4.94M | 6.43M | 5.20M | 3.66M | 0 | 2.76M |
Inventory | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
Other current assets | 9.20M | 9.78M | 8.08M | 6.83M | 5.53M | 4.25M | 1.84M | 1.72M |
Total current assets | 156.44M | 288.85M | 379.28M | 308.42M | 355.24M | 214.55M | 175.53M | 234.68M |
Non-current assets: | ||||||||
Property, Plant and Equipment | 7.03M | 10.59M | 14.11M | 14.52M | 19.47M | 23.89M | 24.87M | 27.19M |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term investments | 2.45M | 3.95M | 1.49M | 1.49M | 1.87M | 0 | 45.15M | 12.70M |
Other non-current assets | 2.93M | 3.99M | 7.49M | 4.59M | 3.80M | 7.63M | 3.38M | 2.41M |
Total non-current assets | 12.42M | 18.54M | 23.10M | 20.61M | 25.15M | 31.52M | 73.40M | 42.31M |
Total assets | 168.86M | 307.40M | 402.38M | 329.04M | 380.40M | 246.08M | 248.94M | 276.99M |
Liabilities | ||||||||
| Current liabilities: | ||||||||
Accounts payable | ||||||||
Deferred revenue | 0 | 366K | 17.77M | 0 | 4.87M | 19.02M | 21.35M | 19.07M |
Short term debt | 0 | 5.38M | 5.07M | 0 | 0 | 0 | 0 | 0 |
Total current liabilities | 20.08M | 47.84M | 61.35M | 42.58M | 39.71M | 41.48M | 36.89M | 37.69M |
| Non-current liabilities: | ||||||||
Long term debt | 0 | 0 | 5.38M | 0 | 0 | 0 | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 149K | 14.20M | 0 | 6.41M | 9.96M | 13.78M | 310.28M | 312.82M |
Total non-current liabilities | 149K | 14.20M | 5.38M | 6.41M | 9.96M | 17.72M | 333.02M | 354.36M |
Total liabilities | 20.23M | 47.84M | 66.74M | 49M | 49.68M | 59.20M | 369.91M | 392.05M |
| Data source | Data source | Data source | Data source | Data source |